Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RASP 201

Next Previous
Search
Drug Profile

RASP 201

Alternative Names: DDP-43242; DDP_43242; RASP-201

Latest Information Update: 04 Mar 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Rasna Therapeutics
  • Developer Actavia Life Sciences
  • Class Antineoplastics; Pyrroles; Small molecules; Thiophenes
  • Mechanism of Action Lysine specific demethylase 1 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Acute myeloid leukaemia

Most Recent Events

  • 04 Jan 2024 RASP 201 is still in preclinical trials for Acute myeloid leukaemia in United Kingdom (PO)
  • 04 Jan 2024 Actavia Life Sciences announces intention to submit IND application for Acute myeloid leukaemia
  • 31 Dec 2022 Rasna therapeutics has patent pending for seven different patent families relating to LSD1 program in the US, Europe, Australia, Brazil, Canada, China, Eurasia, India, Israel, Japan, Mexico, and South Africa (before December 2022)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top